New Enterprise Associates 16, L.P. SEC EDGAR Filings (CIK 0001694560)

SEC EDGAR filings, ownership reports, and insider transactions for New Enterprise Associates 16, L.P..

Business address
1954 Greenspring Drive, Suite 600, Timonium, MD, 21093
Top holdings (ownership)
MIRM, TRVI, MRKR, and MTCR
Top holdings (Schedule 13D)
TRVI, MRKR, and ALLK
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
New Enterprise Associates 16, L.P. has filed 70 SEC EDGAR filings since 17 Jan 2017

Latest Filings

Recent SEC filings for New Enterprise Associates 16, L.P. including 5, SCHEDULE 13D/A, 4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
5 Open 5 document View SEC filing for 5 5 13 Feb 2026 31 Dec 2025 001-38886
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 13 Feb 2026
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 17 Nov 2025
4 Open 4 document View SEC filing for 4 4 06 Oct 2025 02 Oct 2025 001-40537
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 18 Aug 2025
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 11 Aug 2025
SCHEDULE 13D/A Open SCHEDULE 13D/A document | Open XBRL data View SEC filing for SCHEDULE 13D/A 16 May 2025
SCHEDULE 13D/A Open SCHEDULE 13D/A document | Open XBRL data View SEC filing for SCHEDULE 13D/A 20 Mar 2025
4 Open 4 document View SEC filing for 4 4 23 Dec 2024 23 Dec 2024 001-37939
SCHEDULE 13D/A Open SCHEDULE 13D/A document | Open XBRL data View SEC filing for SCHEDULE 13D/A 23 Dec 2024
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A( 08 Nov 2024
4 Open 4 document View SEC filing for 4 4 03 Oct 2024 01 Oct 2024 001-40537
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A( 21 May 2024
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / MARKER THERAPEUTICS, INC. -- SCHEDULE 13D/A 17 May 2024
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / BLACK DIAMOND THERAPEUTICS, INC. -- SCHEDUL 13 May 2024
4 Open 4 document View SEC filing for 4 4 10 Apr 2024 08 Apr 2024 001-40537
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D 29 Dec 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D 23 Jun 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 15 Jun 2023 13 Jun 2023 001-38981
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 02 Dec 2022 30 Nov 2022 001-39343
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / AKOUOS -- SCHEDULE 13D/A(#1) 28 Oct 2022
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. / ALLAKOS INC. -- SCHEDULE 13D 11 Oct 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / GENOCEA BIOSCIENCES -- SCHEDULE 13D/A5E 27 May 2022
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 May 2022 24 May 2022 001-36289
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A3 25 Apr 2022
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 Apr 2022 11 Apr 2022 001-38886
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / METACRINE -- SCHEDULE 13D/A1E 05 Jan 2022
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 27 Dec 2021 10 Dec 2021 001-39512
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A2 02 Nov 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 Oct 2021 18 Oct 2021 001-38886
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / GENOCEA BIOSCIENCES -- SCHEDULE 13D/A4 14 Apr 2021
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. (MARKER THERAPEUTICS) - SCHEDULE 13DA1 26 Mar 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 18 Mar 2021 16 Mar 2021 001-37939
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 16 Mar 2021 09 Mar 2021 001-35670
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. (ALLAKOS) - SCHEDULE 13DA1E 11 Mar 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 07 Dec 2020 04 Dec 2020 001-35670
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. / METACRINE -- SCHEDULE 13D 28 Sep 2020
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Sep 2020 18 Sep 2020 001-39512
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 15 Sep 2020 15 Sep 2020 001-39512
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / GENOCEA BIOSCIENCES -- SCHEDULE 13D/A3 03 Aug 2020
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 Jul 2020 24 Jul 2020 001-36289
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. / AKOUOS -- SCHEDULE 13D 07 Jul 2020
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 01 Jul 2020 30 Jun 2020 001-39343
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 25 Jun 2020 25 Jun 2020 001-39343
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. -- SCHEDULE 13DA1 16 Apr 2020
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 Apr 2020 03 Apr 2020 001-38886
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. - BLACK DIAMOND THERAPEUTICS, INC. -- SCHEDUL 13 Feb 2020
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 29 Jan 2020 29 Jan 2020 001-39200
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Dec 2019 24 Dec 2019 001-35670
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. - MIRUM PHARMACEUTICALS, INC. 13D 30 Jul 2019
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 24 Jul 2019 22 Jul 2019 001-38981
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 17 Jul 2019 17 Jul 2019 001-38981
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. - GENOCEA BIOSCIENCES 13D/A (#2) 28 Jun 2019
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 25 Jun 2019 24 Jun 2019 001-36289
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. - X4 PHARMACEUTICALS, INC. 13D/A1 28 May 2019
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. - TREVI THERAPEUTICS, INC. 13D 20 May 2019
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 May 2019 09 May 2019 001-38886
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 May 2019 07 May 2019 001-35670
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 07 May 2019 07 May 2019 001-38886
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. - GENOCEA BIOSCIENCES 13D/A (#1) 22 Feb 2019
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 Feb 2019 14 Feb 2019 001-36289
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. - MARKER THERAPEUTICS, INC. 13D 25 Oct 2018
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 18 Oct 2018 17 Oct 2018 001-37939
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. - ALLAKOS INC. 13D 27 Jul 2018
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. - GENOCEA BIOSCIENCES, INC. 13D 26 Jan 2018
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 23 Jan 2018 19 Jan 2018 001-36289
SC 13D Open SC 13D document View SEC filing for SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. - ARSANIS, INC. 13D 29 Nov 2017
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 20 Nov 2017 20 Nov 2017 001-38295
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 31 Jul 2017 24 Jul 2017 001-35670
D Open D document View SEC filing for D 17 Jan 2017 021-278594

About this filer

New Enterprise Associates 16, L.P. files with the SEC under CIK 0001694560. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages